Comments to FDA: Pilot Program to Evaluate Proposed Name Submissions

Docket Number:

FDA-2008-N-2081

These comments are submitted in response to the public meeting held June 5 and 6, 2008, on evaluating proposed proprietary names for drug products.

Issues:

OTC Medicines